IL-1β mediates leptin induction during inflammation
Raffaella Faggioni(San Francisco VA Medical Center), Carl Grünfeld(San Francisco VA Medical Center), Charles A. Dinarello(University of Colorado Health), Giamila Fantuzzi(University of Illinois Chicago), Kenneth R. Feingold, John Fuller(University of Verona)
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
January 1, 1998
Cited by 301
Related Papers
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
|The Lancet|2004|3.8k
Vascular Risk Factors and Diabetic Neuropathy
|New England Journal of Medicine|2005|1.3k
Differential requirement for the activation of the inflammasome for processing and release of IL-1β in monocytes and macrophages
|Blood|2008|777
Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes
|The Lancet|1998|743
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
|Proceedings of the National Academy of Sciences|2018|556